I.

Drug Study
Name of Classificati Route/ Action Indicatio Drug Adverse Nursing
Drug on Dosage n Interactio Reaction Consideration
and n
Frequen
cy
Nonsteroid 30 mg, May inhibit Short- Anti- CNS:
Ketorolac al anti- IVTT, prostagland term hypertensi Head  Correct
tromethami inflammato PRN in managem ves, ache, hypovole
ne ry drug when synthesis, ent of diuretics: Dizzi mia
pain to produce moderatel May ness, before
occurs, anti- y severe, decrease drows giving.
q6° inflammato acute pain effectivene iness,
ry, ss. sedati  Carefully
analgesic, on observe
and CV: patients
antipyretic arrhyt with
effects. hmias coagulop
, athies
edem and those
a, taking
hyper anticoagu
tensio lants.
n,
palpit  Drug
ations inhibit
SKIN: platelet
diaph aggregati
oresis on and
, can
prurit prolong
us, bleeding
rash time.
GI:
dyspe  Serious
 psia, GI
GI toxicity,
pain, including
nause peptic
a, ulcers
consti and
patio bleeding,
n, can occur
diarrh in patient
ea, taking
flatul NSAIDs,
ence, despite
peptic lack of
ulcera symptom
tion, s.
stoma
titis,
vomit
ing
Hematolog
ic:
decre
ased
platel
et
adhes
ion,
prolo
nged
bleedi
ng
time,
purpu
ra
Other: pain
 in the
inject
ion
site

Name of Classificatio Route/ Action Indication Adverse Reaction Nursing

Drug n Dosage Consideration
and
Frequenc
y
Cefuroxim Anti-infective 750 mg Inhibits Perioperativ CV: phlebitis,
e a 2nd every q8o, cell-wall e thrombophleb  Check for
generation IVTT synthesis, prophylaxis itis doctor’s
cephalosporin promotin SKIN: order
g osmotic maculopapula  Perform
instability r and ANST
erythematous prior to
rashes, admission
urticaria,  Should not
pain, be given if
induration, positive
sterile skin test
abscesses,  Slow IV
 temperature push
elevation  Inform the
GI: diarrhea, patient
pseudomembr about the
anous colitis, possible
nausea, side effect
anorexia, of the drug
vomiting  Advise
Hematologic: patient to
hemolytic report any
anemia, discomfort
thrombocytop on the IV
enia, transient insertion
neutropenia, site
eosinophilia
Other: anaphylaxis,
hypersensitivi
ty to actions,
serum
sickness
 Name of Classificati Route/ Action Indication Adverse Reaction Nursing
Drug on Dosage Consideration
and
Frequen
cy
Metronidaz Amebicides 500mg Direct-acting Liver CNS: headache,  Monitor
ole and IVTT trichomonaci abscess vertigo, seizure, liver
antiprotozo q8° NST de and Bacterial fever, ataxia, function
al; amebicide infection dizziness, test
nitroimidaz that works caused by syncope, results
ole inside and anaerobic irritability, carefully
outside the microorgani incoordination,  Observe
intestines. sm confusion, patient
It’s thought depression,wea for
to enter the kness, edema
cells of insomnia, especiall
microorganis peripheral y if he is
ms that neuropathy receivin
contain CV: flatten T waves, g
nitroreductas edema, corticost
e, forming flushing, eroids
unstable thrombophlebiti  Tell
compounds s after IV patient
that bind to infusion he may
DNA and EENT: rhinitis, experien
inhibit sinusitis, ce a
synthesis, pharyngitis metallic
causing cell GI: nausea, taste and
death. abdominal have a
cramping or dark or
 pain, stomatitis, red-
epigastric brown
distress, urine
vomiting,
anorexia,
diarrhea,
constipation,
proctitis, dry
mouth, metallic
taste
GU: darken urine,
polyuria,
dysuria, genital
pruritus
HEMATOLOGIC:
transient
leucopenia,
neutropenia
MUSCULOSKELET
AL: transient
joint pain
RESPIRATORY:
upper
respiratory tract
infection
SKIN: rash

Name of Classification Route/ Action Indication Adverse Nursing

Drug Dosage Reaction Consideration
and
Frequenc
y
Ranitidin Anti-ulcer drug; 50mg Competitivel Maintenance CNS:  Assess
e H2 IVTT y inhibits therapy for heada patient
receptorantagoni q12⁰ action of duodenal or che, for
st histamine on gastric ulcer malais abdomina
the H 2 at Gastroesophagea e, l pain.
receptor sites l reflux disease vertig note
of parietal o presence
cells, EENT: of blood
decreasing blurre in
gastric acid d emesis,
secretion. vision stool, or
HEPATIC: gastric
jaundi aspirate
ce  Drug
Other: may be
anaph added to
ylaxis, total
angioe parentera
dema, l
burnin nutrition
g and solutions
itchin
g at
injecti
on site

Name of Drug Classificatio Route/ Action Indicatio Adverse Nursing

n Dosage n Reaction Consideration
and
Frequenc
y
Metoclopramid Antiemetic; 5mg IV Stimulates To CNS:  Monitor
e dopamine q8° PRN motility of prevent or drowsines bowel
antagonist for nausea upper GI reduce s, anxiety, sounds
and tract, nausea fatigue,  Urge
vomiting increases and restlessnes patient to
lower vomiting s, report
esophageal confusion, persistent
sphincter fever, or serious
tone, and headache, adverse
blocks insomnia reaction
dopamine CV: promptly
receptors at bradycardi  Advice
the a, patient not
chemorecept hypotensio to drink
or trigger n, alcohol
zone. transient during
hypertensi therapy
on,
supreavent
ricular
tachycardi
a
SKIN: rash,
urticaria
GI: bowel
disorders,
diarrhea,
nausea
GU:
incontinen
ce, urinary
frequency
Hematologic:
agranuloc
ytosis,
neutropeni
a
Other: loss of
libido,
prolactin
secretion